Page 181 - Orange Book Cumulative Supplement 10 October 2012
P. 181
A - 44
PATENT & EXCLUSIVITY DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 10 - October 2012
See List footnote for information regarding List content
PATENT PATENT EXCLUSIVITY
EXPIRATION PATENT DELIST EXCLUSIVITY EXPIRATION
APPL/PROD DATE REQUESTED DATE
NO PATENT NO CODES CODE(S)
SILDENAFIL CITRATE - VIAGRA
N020895 003 5250534 Mar 27, 2012
5250534*PED Sep 27, 2012
6469012 Oct 22, 2019 U-155
6469012*PED Apr 22, 2020
SIMVASTATIN; SITAGLIPTIN PHOSPHATE - JUVISYNC
N202343 001 >A> 6699871 Jul 26, 2022 DS DP U-1188
8168637 Jun 26, 2022 DP U-1188
SIMVASTATIN; SITAGLIPTIN PHOSPHATE - JUVISYNC
N202343 002 >A> 6699871 Jul 26, 2022 DS DP U-1188
8168637 Jun 26, 2022 DP U-1188
SIMVASTATIN; SITAGLIPTIN PHOSPHATE - JUVISYNC
N202343 003 >A> 6699871 Jul 26, 2022 DS DP U-1188
8168637 Jun 26, 2022 DP U-1188
SIMVASTATIN; SITAGLIPTIN PHOSPHATE - JUVISYNC
N202343 004 >A> 6303661 Apr 24, 2017 U-1188
>A> 6699871 Jul 26, 2022 DS DP U-1188
>A> 6890898 Feb 02, 2019 U-1191
>A> 6890898 Feb 02, 2019 U-1190
>A> 6890898 Feb 02, 2019 U-1189
>A> 7078381 Feb 02, 2019 U-1188
>A> 7125873 Jul 26, 2022 DP U-1193
>A> 7125873 Jul 26, 2022 DP U-1192
>A> 7125873 Jul 26, 2022 DP U-1190
>A> 7125873 Jul 26, 2022 DP U-1189
>A> 7326708 Apr 11, 2026 DS DP U-1188
>A> 7459428 Feb 02, 2019 U-1189
>A> 8168637 Jun 26, 2022 DP U-1188
SIMVASTATIN; SITAGLIPTIN PHOSPHATE - JUVISYNC
N202343 005 >A> 6303661 Apr 24, 2017 U-1188
>A> 6699871 Jul 26, 2022 DS DP U-1188
>A> 6890898 Feb 02, 2019 U-1191
>A> 6890898 Feb 02, 2019 U-1190
>A> 6890898 Feb 02, 2019 U-1189
>A> 7078381 Feb 02, 2019 U-1188
>A> 7125873 Jul 26, 2022 DP U-1193
>A> 7125873 Jul 26, 2022 DP U-1192
>A> 7125873 Jul 26, 2022 DP U-1190
>A> 7125873 Jul 26, 2022 DP U-1189
>A> 7326708 Apr 11, 2026 DS DP U-1188
>A> 7459428 Feb 02, 2019 U-1189
>A> 8168637 Jun 26, 2022 DP U-1188